A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System

Who May Qualify: - Symptomatic paroxysmal Atrial Fibrillation (AF) who, in the opinion of the investigator, are candidates for catheter ablation for AF - Refractory (that is, ineffective, not tolerated, or not desired) or contraindicated to at least one Class I/III antiarrhythmic drugs (AAD) - Willing and capable of providing consent - Able and willing to comply with all pre-, post-, and follow-up testing and requirements Who Should NOT Join This Trial: - Previously diagnosed with persistent or long-standing persistent AF (more than \[\>\] 7 days in duration) - Previous surgical or catheter ablation for AF - Significant congenital anomaly or medical problem that in the opinion of the investigator would be a contraindication to catheter ablation for AF - Current enrollment in an investigational study evaluating another device or drug - Life expectancy less than 12 months - Any contraindications as defined in the Protocol Always talk to your doctor about whether this trial is right for you.